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lock-in (P=1.43x10-6). UDVA in the LAL group was 20/20 or
better in 79% of patients post lock-in with good stability
over 12mo compared with 33% of the control patients with
UDVA of 20/20 or better.
● CONCLUSION: These results demonstrate that the LAL is
more effective in achieving target refractions and improving
postoperative UDVA in patients with pre-existing corneal
astigmatism than a standard monofocal lens.
● KEYWORDS: light adjustable lens; monofocal lens;

astigmatism; cataract
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Abstract

● AIM: To evaluate the light adjustable lens (LAL) vs a
standard monofocal lens in achieving target astigmatic
refraction and improving postoperative uncorrected
distance visual acuity (UDVA).
● METHODS: This randomized controlled clinical trial
included 40 patients with pre-existing astigmatism and
visually significant cataract. Twenty-eight patients
received the LAL and 12 control patients received a
monofocal intraocular lens (IOL) after cataract extraction
at a single institution. The patients with the LAL underwent
adjustment by ultraviolet (UV) light postoperatively plus
subsequent lock-in procedures and all patients returned to
clinic for follow up of study parameters at 6, 9, and 12mo.
Manifest refraction, distance visual acuity, and adverse
events were recorded at each visit.
● RESULTS: The mean cylinder before adjustment in
eyes with the LAL was -0.89±0.58 D (-2.00 to 0.00 D) and
-0.34±0.34 D (-1.25 to 0.00 D) after lock-in (P=1.68x10-8).
The mean cylinder in patients with the monofocal lens was
-1.00±0.32 D (-1.50 to -0.50 D) at 17-21d postoperatively,
which was statistically different from the LAL cylinder post

INTRODUCTION
t is estimated that over 15 million cataract surgeries are
performed worldwide each year [1]. In addition to the
primary purpose of cataract removal, many patients undergo
the procedure with high expectations of improved refractive
outcomes. One reason for failing to reach target outcomes is
the presence of astigmatism. As there is a high prevalence of
astigmatism preoperatively in patients undergoing cataract
surgery, achieving emmetropia after surgery may be hindered
by either residual or surgically induced astigmatism. Xu and
Zheng[2] found 33% of patients undergoing cataract surgery had
at least 1.00 D of astigmatism, while other studies have shown
64.4% with 0.25-1.25 D[3]. The degree of surgically induced
astigmatism varies by the size and location of the corneal
incision but has been reported as 0.09-1.92 D, and while
the temporal approach leads to the least amount of induced
astigmatism, the effectiveness is limited by preoperative
astigmatism[4].
Since the first in vivo study in rabbits in 2003 demonstrated
successful power adjustment, the RxSight Inc. (Aliso Viejo,
California, USA) light adjustable lens (LAL) has been explored

I

1101

Astigmatic correction with LAL vs monofocal lens

as a potential advancement in improving postoperative visual
outcomes after cataract surgery[5]. Multiple prospective human
studies have since shown the ability of the LAL to achieve
a target spherical and cylindrical refraction and the lens
was approved by the food and drug administration (FDA)
in November of 2017[6-13]. The LAL is a foldable, posterior
chamber three-piece silicone lens with polymethylmethacrylate
modified-C haptics and a 6.0 mm optic with a length of 13.0 mm.
With application of ultraviolet (UV) light, it has the capacity to
adjust spherical power from -2.00 to +2.00 D and cylindrical
power from -0.75 to -2.00 D by 0.25 D increments. A light
delivery device administers 365 nm UV light from a mercury
arc light source on a standard slit lamp to adjust lens power
and to lock-in the lens power once the desired refractive
outcomes have been reached. This single site analysis of
patients with pre-existing corneal astigmatism is the first
report of a randomized controlled clinical study to evaluate the
effectiveness of the LAL vs a monofocal intraocular lens (IOL)
in achieving target refractive outcomes.
SUBJECTS AND METHODS
Ethical Approval This is a primary site analysis of a
prospective randomized controlled, multi-center phase III FDA
clinical trial. Approval for this study was received from Salus
IRB (Austin, Texas) and all participants gave informed consent
according to the Declaration of Helsinki. This trial is registered
with www.clinicaltrials.gov (NCT01496066).
Forty patients (40 total eyes) with visually significant cataract
were selected to participate in this study. These subjects
fulfilled all inclusion criteria including pupil diameter of
≥7.0 mm with full dilation and preoperative astigmatism
between -0.75 and -2.50 D by manual keratometry with a
steep axis between 70 and 110 degrees. Patients with irregular
astigmatism, receiving photosensitizing systemic medication,
or with significant anterior or posterior segment pathology
with the potential to limit visual acuity were excluded from the
study.
Each subject received a preoperative complete ophthalmic
examination. This examination included ocular history,
uncorrected distance visual acuity (UDVA) and best corrected
distance visual acuity (CDVA), slit lamp examination,
manifest refraction, manual keratometry, and fundus exam.
Randomization was performed using Medrio EDC (San
Francisco, California, USA) immediately before surgery by a
2:1 ratio to the LAL or control group, which received a single
piece acrylic ZCBOO (Abbott, Santa Clara, California, USA)
monofocal IOL. Patients were stratified based on preoperative
cylinder power (0.75 to 1.25 D and 1.375 to 2.50 D). Selection
of the implantable lens was based on ocular biometry and
power calculation from IOL Master (V5.02, Carl Zeiss AG,
Oberkochen, Germany) with the recommended manufacturer
1102

A-constant. Patients in the control group received an IOL
targeted for postoperative emmetropia. Those in the LAL
group were initially targeted to a postoperative manifest
refraction spherical equivalent (MRSE) of +0.50 D to allow
for a potential myopic shift from the lock-in treatment.
Both the LAL and control monofocal lenses were implanted
using standard surgical technique including 2.4 mm clear
temporal corneal incision, capsulorhexis (5.5 mm), and nuclear
fragmentation using divide and conquer technique with
phacoemulsification. All surgical instruments and methods
were identical across the LAL and control groups. No limbal
relaxing incision (LRI) was performed during surgery in either
group. Postoperatively, all patients received moxifloxacin
0.5% (Alcon, Fort Worth, Texas, USA) and were instructed
to use q.i.d. until the bottle was finished. Ketorolac 0.5% was
also used q.i.d. until the bottle was finished and prednisolone
acetate 1% was given with instructions on a tapering regimen
over the course of four weeks. Patients in the LAL group
were instructed to wear UV protective eyewear at all times
while outdoors until after the final lock-in procedure was
completed. Patients presented for an initial adjustment between
17-21d postoperatively. At this visit, those with a cylinder
power ≤-0.75 D underwent spherocylindrical adjustment
while patients with >-0.75 D of cylindrical power underwent
spherical adjustment alone. Upon return 3-5d from the initial
adjustment, a manifest refraction was again determined, and a
second adjustment was performed if needed. After the desired
refraction was obtained, patients in the LAL group received
two lock-in procedures, also separated by 3-5d. Patients
returned one week after the final lock-in procedure and post
lock-in MRSE, UDVA, and CDVA were recorded. All patients
returned to clinic at six months, nine months, and 12mo
postoperatively to assess stability of these values over time. A
masked observer measured refraction and visual acuity at each
postoperative visit in both groups.
The data was collected and analyzed using Microsoft Excel
(2016). Results are described by mean, standard deviation,
and range. A student t-test was performed using a P value =
0.05 to determine significance. Statistical analysis of visual
acuity was performed by conversion to logMAR as described
by Holladay [14]. The London Clinic Standard Graphs for
Refractive Surgery was used to create standard refractive
graphs[15].
RESULTS
Patient demographics, axial length (AL), K1, K2, anterior
chamber depth, mean spherical equivalent (SEQ), sphere, and
cylinder were recorded for each group (Table 1). The mean
SEQ of the patients in the LAL group before adjustment (1721d postoperatively) was 0.54±0.39 D (-0.13 to 1.25 D) and
after lock-in was 0.05±0.31 D (-0.50 to 0.88 D). The mean
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Table 1 Patient demographics
Value
Patients
Males

Control

Light adjustable lens

12
6

28
14

Females

6

14

Age (y)

67 (42 to 79)

66 (45 to 76)

Eyes (total)

12

28

Right eyes

8

20

Left eyes

4

8

Axial length (mm)

24.54 (22.31 to 26.29)

23.97 (22.07 to 27.06)

K1 (D)

43.77 (41.56 to 48.56)

43.68 (41.31 to 46.94)

K2 (D)

44.94 (42.13 to 49.49)

44.92 (42.03 to 47.67)

Anterior chamber depth (mm)
Sphere (D)
Cylinder (D)

3.23 (2.22 to 3.81)

3.46 (2.21 TO 4.66)

-1.15 (-5.50 to 2.75)
-1.06 (-1.75 to -0.25)

-1.23 (-7.50 to 3.00)
-1.04 (-3.25 to 0.00)

Table 2 Spherical equivalent

mean±SD (range)
Number of
eyes

Spherical equivalent
refraction

Sphere

Cylinder

Preoperative

28

-1.75±3.04 (-8.13 to 2.50)

-1.23±3.00 (-7.50 to 3.00)

-1.04±0.81 (-3.25 to 0.00)

Preadjustment

28

0.54±0.39 (-0.13 to 1.25)

0.99±0.52 (0.00 to 2.00)

-0.89±0.58 (-2.00 to 0.00)

Post-lock-in

28

0.05±0.31 (-0.50 to 0.88)

0.22±0.31 (-0.25 to 1.00)

-0.34±0.34 (-1.25 to 0.00)

6mo

28

-0.05±0.31 (-0.63 to 0.50)

0.22±0.37 (-0.25 to 1.25)

-0.55±0.62 (-3.25 to 0.00)

Time period
Light adjustable lens (D)

9mo

28

0.10±0.35 (-0.50 to 1.00)

0.32±0.45 (-0.25 to 1.50)

-0.45±0.48 (-2.00 to 0.00)

12mo

28

0.02±0.31 (-0.88 to 0.63)

0.23±0.37 (-0.50 to 1.00)

-0.42±0.44 (-1.75 to 0.00)

Preoperative

12

-1.68±3.00 (-6.25 to 2.50)

-1.15±2.96 (-5.50 to 2.75)

-1.06±0.50 (-1.75 to -0.25)

Postoperative

12

-0.29±0.49 (-1.38 to 0.38)

0.21±0.50 (-0.75 to 0.75)

-1.00±0.32 (-1.50 to -0.50)

Post-lock-in

0

N/A

N/A

N/A

6mo

12

-0.04±0.44 (-0.75 to 1.00)

0.38±0.42 (-0.25 to 1.25)

-0.83±0.37 (-1.50 to -0.25)

9mo

12

-0.16±0.44 (-0.75 to 0.50)

0.23±0.45 (-0.50 to 0.75)

-0.77±0.29 (-1.25 to -0.25)

12mo

12

0.00±0.45 (-0.63 to 1.00)

0.42±0.48 (-0.25 to 1.25)

-0.83±0.37 (-1.50 to -0.25)

Control (D)

SEQ in patients who received a monofocal lens at 17-21d
postoperatively was -0.29±0.49 D (-1.38 to 0.38 D) as shown
in Table 2. Seventeen of the 28 patients in the LAL group
required 2 adjustments before lock-in but no patients required
more than 2 adjustments.
The mean cylinder before adjustment in the LAL group
was -0.89±0.58 D (-2.00 to 0.00 D) and post lock-in was
-0.34±0.34 D (-1.25 to 0.00 D) with a P value of 1.68×10-8.
In the LAL group post lock-in, 68% of patients achieved
cylindrical correction of 0.25 D or less and 82% achieved 0.50 D
or less of astigmatism (Figure 1). Comparatively, no patients
in the control group at 17-21d postoperatively achieved a
cylindrical correction of 0.25 D or less and only 17% were
found to have 0.50 D or less of astigmatism (Figure 2). The
mean cylinder at 17-21d after surgery in the control eyes
was -1.00±0.32 D (-1.50 to -0.50 D), which was statistically
different from the mean cylinder at post lock-in LAL group
(P=1.43×10-6).

The amount of cylinder in the LAL group post lock-in and at
12mo postoperatively was not statistically different (P=0.287),
though the amount of cylinder was significantly different
between the control and LAL groups at 12mo (P=0.007). Fiftyseven percent of eyes in the LAL group at 12mo were within a
cylinder magnitude of 0.25 D compared with 8% in the control
group while 96% in the LAL group and 75% of the controls
were within 1.00 D (Figure 3). Sixty-eight percent of eyes at
this final visit experienced a change in cylinder within 0.25 D
of the post lock-in value and 89% were within 0.50 D of the
post lock-in value.
Post lock-in results showed 79% of patients with the LAL to
have UDVA of 20/20 or better, 89% 20/25 or better, and 100%
of patients were 20/32 or better (Figure 4). Of the control
patients at 17-21d postoperatively, 33% were found to have
UDVA of 20/20 or better, 66% were 20/25 or better and 100%
at 20/32 or better. UDVA in the LAL patients remained stable
over 12mo postoperatively. Visual acuity at six, nine, and
1103
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Figure 1 Standard refractive surgery graphs for the patients who received the light adjustable lens.

Figure 2 Standard refractive surgery graphs for control patients.

12mo was significantly improved from pre-adjustment visual
acuity in patients with the LAL when converted to logMAR.
UDVA was also significantly improved at six and 12mo when
compared with control groups while the nine-month data
showed a P value=0.08. Additionally, 64% of eyes in the LAL
group gained three lines of BCVA compared with 50% of eyes
in the control group and no eye in either group lost lines of
BCVA (Figures 1 and 2).
Adverse events included three patients with the LAL and
one patient in the control group who developed increased
intraocular pressure (IOP); one patient in each group required
treatment for this increase in IOP which subsequently resolved
within one week. The two patients in the LAL group not
requiring pressure lowering therapy continued with mildly
1104

elevated IOP throughout the duration of the study. One
patient in the LAL group developed trigeminal neuralgia and
one patient had a stroke. One patient in both the LAL and
control group described glare and halos postoperatively which
resolved within one week. No patients developed macular
edema or uveitis.
DISCUSSION
Many patients undergo cataract surgery with the goal of
achieving spectacle independence postoperatively, yet various
factors including keratometry, AL, anterior chamber depth,
and correct IOL power and position contribute to the difficulty
in consistently achieving optimal UDVA[16]. A number of
studies have demonstrated the unpredictability of IOL power
calculations, particularly in short eyes (AL<22 mm) and
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Figure 3 Cumulative percentages of cylindrical power in patients
who received the control lens (at 12mo postoperatively) vs LAL
(light adjustable lens) pre-adjustment, after the final lock-in
procedure, and at 12mo postoperatively.

Figure 4 Uncorrected distance visual acuity in patients with the
light adjustable lens vs monofocal lens pre-adjustment, post lockin, and 12mo postoperatively The control data for pre-adjustment
and post lock-in was obtained at 17-21d postoperatively.

long eyes (AL>26 mm)[17]. Multiple formulas for calculating
IOL power including Haigis, Hoffer Q, Holladay, Barrett
Universal II, Olsen, SRK/T, and T2 have been created in an
attempt to improve target refractions. While Kane found the
Barrett Universal II formula to have the lowest mean absolute
prediction error over the entire AL range, 27.7% of eyes after
cataract surgery were more than 0.50 D from target refraction
with no significant improvement when compared with newer
formulas[18-19]. Even with careful preoperative calculations,
the final position of the IOL cannot always be accurately
predicted[16].
As the LAL allows for adjustment of the lens power
postoperatively, this advancement allows the surgeon to
overcome sources of residual refractive error in cataract
surgery and significantly reduce the need for postoperative
corrective lenses. Previous pilot studies and prospective
clinical trials have demonstrated the success of the LAL in

correcting myopia and hyperopia after cataract surgery with
88%-100% of patients achieving target spherical correction
within 0.50 D[6-7,10,12,20]. Comparatively, Liu et al[21] reported
only 61.3% of patients are between -1.00 D and 1.00 D after
cataract surgery. The fact that the accuracy of the LAL is
within 0.25 D and the majority of patients in our study needed
multiple adjustments further illustrates the need for technology
capable of altering lens characteristics postoperatively. As
noted above, postoperative MRSE was initially targeted for
+0.5 D in the LAL group to compensate for a small myopic
shift that has been described following lock-in treatment.
The cause of this shift is not completely understood. Possible
explanations have included an anterior axial shift of the IOL
during lock-in treatment or variable UV penetration of the IOL
secondary to corneal properties affecting the transmission of
UV light through the cornea in a nonuniform manner. Further
studies are needed to elucidate the etiology of these findings.
The LAL has also been demonstrated to effectively reduce
cylindrical power with stability over time[8,12-13,22]. Although
previous studies have examined the performance of RxSight’s
LAL, this is the first report of a randomized controlled study
to evaluate visual and refractive outcomes in patients receiving
the LAL vs monofocal lenses. While our study demonstrated
slightly fewer patients achieving astigmatic correction of
0.50 D or less than previous studies (82% after lock-in and
71% at 12mo postoperatively), the mean cylinder in patients
with an LAL was found to be significantly less when compared
with the patients who received a monofocal lens[8,22].
There are a number of alternatives to the LAL for astigmatic
correction in cataract surgery that must be evaluated and
compared with the efficacy and safety of the LAL. Insertion
of a toric IOL or a peripheral corneal relaxing incision may be
performed during surgery to correct pre-existing astigmatism.
A recent meta-analysis found toric IOLs to be more effective
than non-toric lenses combined with limbal relaxing insision
(LRI), yet only 64.8% achieved an UDVA of 20/25 compared
with 39.6% in the non-toric and LRI patients[23]. Our data found
that 79% of patients who received the LAL reached 20/20 post
lock-in and 89% reached 20/25 with relative stability over
one year. Residual refractive cylindrical error has also been
demonstrated in patients receiving toric lenses as 52% within
a magnitude of 0.50 D and 40% in patients undergoing LRI
at time of surgery[24]. Therefore, even though toric rotational
stability has improved over recent years, it is susceptible to the
same errors as monofocal lenses in achieving target refractive
outcomes and our study demonstrates potential superiority of
the LAL in reaching refractive goals.
Residual refractive error after cataract surgery may also be
corrected by corneal refractive surgery[25-26]. However, there
are additional risks associated with these procedures including
1105
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dry eye and corneal ectasia[27-28]. The LAL and control groups
in our study experienced similar rates of complications. The
patient that had a stroke had pre-existing risk factors. While
one patient developed trigeminal neuralgia, we do not believe
this adverse event was due to implantation of the LAL. Of
note, the literature is scarce regarding reports of this occurring
after cataract surgery. While further studies with larger sample
sizes are needed, the LAL does not appear to carry increased
risks beyond what is associated with conventional implantable
lenses in cataract surgery. Subgroup analysis of with-the-rule
(WTR), against-the-rule (ATR), and oblique astigmatisms,
including astigmatism vector analysis, would be beneficial to
this study but were limited by a small sample size. Additional
follow-up indices including corneal topography would be
beneficial for further studies on the LAL.
Many other technologies are being developed as a means
to correct residual refractive error after cataract surgery
including the magnetically adjustable IOL, liquid crystal IOL,
and adjustment by the femtosecond laser. Adjustment by the
femtosecond laser is especially promising as laser application
may cause shrinkage or a release of tension on the concentric
IOL material, allowing for adjustment of the lens at any
time postoperatively[29]. Currently, these have yet to undergo
evaluation in a randomized clinical trial but may provide
additional options for noninvasive adjustment in the future.
While alternative treatments to limit astigmatism after cataract
surgery are available, the LAL is at the forefront of technology
that allows for postoperative refractive correction. Additionally,
it has the potential to achieve more accurate target refractions
than current intraoperative options without incurring the risks
of additional procedures.
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